Financhill
Buy
70

JBL Quote, Financials, Valuation and Earnings

Last price:
$237.43
Seasonality move :
1.26%
Day range:
$227.74 - $232.74
52-week range:
$108.66 - $237.14
Dividend yield:
0.14%
P/E ratio:
35.46x
P/S ratio:
0.80x
P/B ratio:
16.10x
Volume:
668.3K
Avg. volume:
1.3M
1-year change:
58.46%
Market cap:
$24.4B
Revenue:
$29.8B
EPS (TTM):
$6.43
Period Ending 2021-08-31 2022-08-31 2023-08-31 2024-08-31 2025-08-31
Revenue $29.3B $33.5B $34.7B $28.9B $29.8B
Revenue Growth (YoY) 7.4% 14.32% 3.66% -16.77% 3.18%
 
Cost of Revenues $27.2B $30.9B $31.9B $26.2B $27.2B
Gross Profit $2.1B $2.6B $2.8B $2.7B $2.6B
Gross Profit Margin 7.21% 7.8% 8.19% 9.33% 8.84%
 
R&D Expenses $34M $33M $34M $39M $26M
Selling, General & Admin $1.2B $1.2B $1.2B $1.2B $1.1B
Other Inc / (Exp) $3M -$34M -$126M $487M --
Operating Expenses $1.2B $1.2B $1.2B $1.2B $1.1B
Operating Income $867M $1.4B $1.6B $1.5B $1.5B
 
Net Interest Expenses $127M $149M $208M $176M $150M
EBT. Incl. Unusual Items $944M $1.2B $1.3B $1.8B $892M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $246M $235M $444M $363M $235M
Net Income to Company $698M $996M $818M $1.4B $657M
 
Minority Interest in Earnings $2M -- -- -- --
Net Income to Common Excl Extra Items $698M $996M $818M $1.4B $657M
 
Basic EPS (Cont. Ops) $4.69 $7.05 $6.15 $11.34 $6.00
Diluted EPS (Cont. Ops) $4.58 $6.90 $6.02 $11.17 $5.92
Weighted Average Basic Share $148.5M $141.2M $133M $122.4M $109.5M
Weighted Average Diluted Share $152.1M $144.4M $135.9M $124.3M $110.9M
 
EBITDA $1.7B $2.4B $2.5B $2.2B $2.2B
EBIT $867M $1.4B $1.6B $1.5B $1.5B
 
Revenue (Reported) $29.3B $33.5B $34.7B $28.9B $29.8B
Operating Income (Reported) $867M $1.4B $1.6B $1.5B $1.5B
Operating Income (Adjusted) $867M $1.4B $1.6B $1.5B $1.5B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $8.6B $9.6B $8.4B $7B $8.3B
Revenue Growth (YoY) 9.38% 12.47% -12.95% -16.61% 18.75%
 
Cost of Revenues $7.9B $8.9B $7.6B $6.4B $7.6B
Gross Profit $657M $775M $806M $613M $723M
Gross Profit Margin 7.67% 8.04% 9.61% 8.77% 8.71%
 
R&D Expenses $9M $9M $10M $8M $7M
Selling, General & Admin $308M $319M $314M $305M $344M
Other Inc / (Exp) -$1M -$60M -$163M -$103M --
Operating Expenses $317M $328M $324M $313M $351M
Operating Income $340M $447M $482M $300M $372M
 
Net Interest Expenses $32M $61M $48M $39M $63M
EBT. Incl. Unusual Items $317M $299M $235M $139M $220M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $76M $76M $41M $39M $74M
Net Income to Company $241M $223M $194M $100M $146M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $241M $223M $194M $100M $146M
 
Basic EPS (Cont. Ops) $1.67 $1.65 $1.50 $0.89 $1.36
Diluted EPS (Cont. Ops) $1.63 $1.62 $1.47 $0.88 $1.35
Weighted Average Basic Share $144.1M $134.8M $129.6M $112.7M $107M
Weighted Average Diluted Share $147.7M $138M $132.1M $114M $108.3M
 
EBITDA $609M $710M $688M $482M $639M
EBIT $340M $447M $482M $300M $372M
 
Revenue (Reported) $8.6B $9.6B $8.4B $7B $8.3B
Operating Income (Reported) $340M $447M $482M $300M $372M
Operating Income (Adjusted) $340M $447M $482M $300M $372M
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $30B $34.5B $33.5B $27.5B $31.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $27.6B $31.7B $30.7B $25B $28.4B
Gross Profit $2.4B $2.8B $2.8B $2.5B $2.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $35M $33M $35M $37M $25M
Selling, General & Admin $1.2B $1.2B $1.2B $1.2B $1.2B
Other Inc / (Exp) -- -$93M -$229M $547M --
Operating Expenses $1.3B $1.2B $1.2B $1.2B $1.2B
Operating Income $1.1B $1.6B $1.5B $1.3B $1.6B
 
Net Interest Expenses $129.1M $178M $204M $167M $172M
EBT. Incl. Unusual Items $975.8M $1.2B $1.2B $1.7B $973M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $237.5M $235M $409M $361M $270M
Net Income to Company $738M $978M $789M $1.3B $703M
 
Minority Interest in Earnings $1.2M -- -- -- --
Net Income to Common Excl Extra Items $738.4M $978M $789M $1.3B $703M
 
Basic EPS (Cont. Ops) $5.03 $7.05 $5.99 $10.57 $6.51
Diluted EPS (Cont. Ops) $4.90 $6.90 $5.87 $10.42 $6.43
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.1B $2.5B $2.4B $2B $2.3B
EBIT $1.1B $1.6B $1.5B $1.3B $1.6B
 
Revenue (Reported) $30B $34.5B $33.5B $27.5B $31.1B
Operating Income (Reported) $1.1B $1.6B $1.5B $1.3B $1.6B
Operating Income (Adjusted) $1.1B $1.6B $1.5B $1.3B $1.6B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Revenue $8.6B $9.6B $8.4B $7B $8.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7.9B $8.9B $7.6B $6.4B $7.6B
Gross Profit $657M $775M $806M $613M $723M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $9M $9M $10M $8M $7M
Selling, General & Admin $308M $319M $314M $305M $344M
Other Inc / (Exp) -$1M -$60M -$163M -$103M --
Operating Expenses $317M $328M $324M $313M $351M
Operating Income $340M $447M $482M $300M $372M
 
Net Interest Expenses $32M $61M $48M $39M $63M
EBT. Incl. Unusual Items $317M $299M $235M $139M $220M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $76M $76M $41M $39M $74M
Net Income to Company $241M $223M $194M $100M $146M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $241M $223M $194M $100M $146M
 
Basic EPS (Cont. Ops) $1.67 $1.65 $1.50 $0.89 $1.36
Diluted EPS (Cont. Ops) $1.63 $1.62 $1.47 $0.88 $1.35
Weighted Average Basic Share $144.1M $134.8M $129.6M $112.7M $107M
Weighted Average Diluted Share $147.7M $138M $132.1M $114M $108.3M
 
EBITDA $609M $710M $688M $482M $639M
EBIT $340M $447M $482M $300M $372M
 
Revenue (Reported) $8.6B $9.6B $8.4B $7B $8.3B
Operating Income (Reported) $340M $447M $482M $300M $372M
Operating Income (Adjusted) $340M $447M $482M $300M $372M
Period Ending 2021-08-31 2022-08-31 2023-08-31 2024-08-31 2025-08-31
Cash and Equivalents $1.6B $1.5B $1.8B $2.2B $2B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.1B $5.2B $4.7B $4.6B $5.1B
Inventory $4.4B $6.1B $5.2B $4.3B $4.7B
Prepaid Expenses $757M $1.1B $1.1B $1.7B --
Other Current Assets -- -- -- -- --
Total Current Assets $10.9B $13.9B $14.7B $12.8B $13.7B
 
Property Plant And Equipment $4.5B $4.5B $3.5B $3.4B $3.3B
Long-Term Investments $9M $13M -- -- --
Goodwill $715M $704M $621M $661M --
Other Intangibles $182M $158M $142M $143M --
Other Long-Term Assets $239M $294M $268M $276M --
Total Assets $16.7B $19.7B $19.4B $17.4B $18.5B
 
Accounts Payable $6.8B $8B $5.7B $6.2B $7.9B
Accrued Expenses $2.3B $3.7B $3.9B $3.8B --
Current Portion Of Long-Term Debt -- $300M -- -- --
Current Portion Of Capital Lease Obligations $108M $119M $104M $93M --
Other Current Liabilities -- -- $1.4B -- --
Total Current Liabilities $10.7B $13.7B $12.7B $11.8B $13.7B
 
Long-Term Debt $3.4B $3.2B $3.1B $3.4B $2.9B
Capital Leases -- -- -- -- --
Total Liabilities $14.5B $17.3B $16.6B $15.6B $17B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$25M -$42M -$17M -$46M --
Common Equity $2.1B $2.5B $2.9B $1.7B $1.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1M $1M $1M -- $4M
Total Equity $2.1B $2.5B $2.9B $1.7B $1.5B
 
Total Liabilities and Equity $16.7B $19.7B $19.4B $17.4B $18.5B
Cash and Short Terms $1.6B $1.5B $1.8B $2.2B $2B
Total Debt $3.5B $3.6B $3.2B $3.5B $3.6B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Cash and Equivalents $1.2B $1.2B $1.6B $2.1B $1.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $5.1B $5.8B $4.8B $4.8B $5.6B
Inventory $4.7B $6.4B $5.1B $4.3B $4.7B
Prepaid Expenses $852M $1.3B -- -- --
Other Current Assets -- -- $1.2B $2B --
Total Current Assets $11.8B $14.7B $14.7B $13.2B $14.4B
 
Property Plant And Equipment $4.4B $4.5B $3.5B $3.3B $3.3B
Long-Term Investments $9M $19M -- $1M --
Goodwill $713M $708M $661M $670M --
Other Intangibles $173M $150M $177M $168M --
Other Long-Term Assets $268M $310M $279M $280M --
Total Assets $17.6B $20.5B $19.4B $17.8B $19.3B
 
Accounts Payable $7.5B $8B $5.6B $6.9B $8.4B
Accrued Expenses $2.4B $4B $4.3B $3.7B --
Current Portion Of Long-Term Debt $500M $300M -- -- --
Current Portion Of Capital Lease Obligations $111M $129M $96M $93M --
Other Current Liabilities -- -- $1.5B -- --
Total Current Liabilities $12B $14.4B $13B $12.4B $14.5B
 
Long-Term Debt $2.8B $3B $3.1B $3.2B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $15.4B $18B $16.9B $16.2B $17.9B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$48M -$22M -$6M -$52M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1M $1M $1M -- $3M
Total Equity $2.2B $2.5B $2.5B $1.6B $1.3B
 
Total Liabilities and Equity $17.6B $20.5B $19.4B $17.8B $19.3B
Cash and Short Terms $1.2B $1.2B $1.6B $2.1B $1.6B
Total Debt $3.3B $3.3B $3.1B $3.2B $3.3B
Period Ending 2021-08-31 2022-08-31 2023-08-31 2024-08-31 2025-08-31
Net Income to Stockholders $698M $996M $818M $1.4B $657M
Depreciation & Amoritzation $876M $925M $924M $696M $674M
Stock-Based Compensation $102M $81M $95M $89M $107M
Change in Accounts Receivable -$167M -$1.1B $438M -$232M -$482M
Change in Inventories -$1.3B -$1.7B $370M $1.2B -$431M
Cash From Operations $1.4B $1.7B $1.7B $1.7B $1.6B
 
Capital Expenditures $1.2B $1.4B $1B $784M $468M
Cash Acquisitions $50M $18M $29M $90M $392M
Cash From Investing -$851M -$858M -$723M $1.4B -$714M
 
Dividends Paid (Ex Special Dividend) $50M $48M $45M $42M $36M
Special Dividend Paid
Long-Term Debt Issued $1.7B $3.8B $4B $2B --
Long-Term Debt Repaid -$1.6B -$3.9B -$4.2B -$2.1B --
Repurchase of Common Stock $428M $696M $487M $2.5B $1B
Other Financing Activities -$85M -$66M -$42M -$73M --
Cash From Financing -$413M -$888M -$680M -$2.7B -$1.2B
 
Beginning Cash (CF) $1.6B $1.5B $1.8B $2.2B $1.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $173M -$89M $326M $397M -$268M
Ending Cash (CF) $1.7B $1.4B $2.1B $2.6B $1.7B
 
Levered Free Cash Flow $274M $266M $704M $932M $1.2B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $241M $223M $194M $100M $146M
Depreciation & Amoritzation $269M $263M $206M $182M $267M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$556M -$320M $48M -- -$90M
Change in Inventories -- -- -- -- --
Cash From Operations -$46M $166M $448M $312M $323M
 
Capital Expenditures $281M $314M $288M $97M $95M
Cash Acquisitions -- -- $59M $63M $124M
Cash From Investing -$73M -$176M -$75M -$136M -$180M
 
Dividends Paid (Ex Special Dividend) $14M $12M $12M $10M $10M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $550M $1B $395M $100M --
Long-Term Debt Repaid -$574M -$1.1B -$436M -$130M --
Repurchase of Common Stock $127M $161M $500M $232M $300M
Other Financing Activities -$43M -$33M -$67M -$40M --
Cash From Financing -$208M -$241M -$620M -$312M -$503M
 
Beginning Cash (CF) $1.2B $1.2B $1.6B $2.1B $1.6B
Foreign Exchange Rate Adjustment -$11M -$10M -$7M -$7M -$1M
Additions / Reductions -$338M -$261M -$254M -$143M -$361M
Ending Cash (CF) $880M $946M $1.3B $1.9B $1.2B
 
Levered Free Cash Flow -$327M -$148M $160M $215M $228M
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $738M $978M $789M $1.3B $703M
Depreciation & Amoritzation $939.2M $919M $867M $672M $759M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $40.5M -$856M $806M -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.3B $1.9B $2B $1.6B $1.7B
 
Capital Expenditures $1.1B $1.4B $1B $593M $466M
Cash Acquisitions $31.6M -- -- $94M $453M
Cash From Investing -$660.1M -$961M -$622M $1.3B -$758M
 
Dividends Paid (Ex Special Dividend) $50.2M $46M $45M $40M $36M
Special Dividend Paid
Long-Term Debt Issued $2.1B $4.2B $3.4B $1.7B --
Long-Term Debt Repaid -$2B -$4.4B -$3.6B -$1.8B --
Repurchase of Common Stock $505M $730M $826M $2.2B $1.1B
Other Financing Activities -$107M -$56M -$76M -$46M --
Cash From Financing -$533.6M -$921M -$1.1B -$2.4B -$1.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $121M -$12M $333M $508M -$486M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $234.4M $445M $1B $987M $1.2B
Period Ending 2021-11-30 2022-11-30 2023-11-30 2024-11-30 2025-11-30
Net Income to Stockholders $241M $223M $194M $100M $146M
Depreciation & Amoritzation $269M $263M $206M $182M $267M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$556M -$320M $48M -- -$90M
Change in Inventories -- -- -- -- --
Cash From Operations -$46M $166M $448M $312M $323M
 
Capital Expenditures $281M $314M $288M $97M $95M
Cash Acquisitions -- -- $59M $63M $124M
Cash From Investing -$73M -$176M -$75M -$136M -$180M
 
Dividends Paid (Ex Special Dividend) $14M $12M $12M $10M $10M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $550M $1B $395M $100M --
Long-Term Debt Repaid -$574M -$1.1B -$436M -$130M --
Repurchase of Common Stock $127M $161M $500M $232M $300M
Other Financing Activities -$43M -$33M -$67M -$40M --
Cash From Financing -$208M -$241M -$620M -$312M -$503M
 
Beginning Cash (CF) $1.2B $1.2B $1.6B $2.1B $1.6B
Foreign Exchange Rate Adjustment -$11M -$10M -$7M -$7M -$1M
Additions / Reductions -$338M -$261M -$254M -$143M -$361M
Ending Cash (CF) $880M $946M $1.3B $1.9B $1.2B
 
Levered Free Cash Flow -$327M -$148M $160M $215M $228M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock